REGENX Biosciences and Voyager Therapeutics Announce License Agreement
June 02, 2014 07:00 ET
|
REGENXBIO Inc.
Voyager acquires rights to REGENX's proprietary NAV® vectors in multiple CNS disorders
Eighth third-party commercial license of REGENX's NAV vectors since 2010
REGENX to receive undisclosed...